Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

被引：62

作者：

Yasui, K ^{[1
]}

Nakaso, K ^{[1
]}

Kowa, H ^{[1
]}

Takeshima, T ^{[1
]}

Nakashima, K ^{[1
]}

机构：

[1] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neurol, Yonago, Tottori 6838504, Japan

来源：

ACTA NEUROLOGICA SCANDINAVICA | 2003年 / 108卷 / 01期

关键词：

D O I：

10.1034/j.1600-0404.2003.00135.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：66 / 67

页数：2

共 6 条

[1] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[2] Homocysteine and neurologic disease [J].

Diaz-Arrastia, R .

ARCHIVES OF NEUROLOGY, 2000, 57 (10) :1422-1427

[3] Homocysteine and vascular disease [J].

Hankey, GJ ;

Eikelboom, JW .

LANCET, 1999, 354 (9176) :407-413

[4] Elevated plasma levels of homocysteine in Parkinson's disease [J].

Kuhn, W ;

Roebroek, R ;

Blom, H ;

van Oppenraaij, D ;

Przuntek, H ;

Kretschmer, A ;

Büttner, T ;

Woitalla, D ;

Müller, T .

EUROPEAN NEUROLOGY, 1998, 40 (04) :225-227

[5] Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype [J].

Nakaso, K ;

Yasui, K ;

Kowa, H ;

Kusumi, M ;

Ueda, K ;

Yoshimoto, Y ;

Takeshima, T ;

Sasaki, K ;

Nakashima, K .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 207 (1-2) :19-23

[6] Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD [J].

Yasui, K ;

Kowa, H ;

Nakaso, K ;

Takeshima, T ;

Nakashima, K .

NEUROLOGY, 2000, 55 (03) :437-440

← 1 →